Shugart L, Chastain B
Enzyme. 1979;24(6):353-7. doi: 10.1159/000458689.
Structural analogues of adenosylhomocysteine (AdoHcy) have been tested as inhibitors of a tRNA(uracil-5-)-methyltransferase preparation obtained from Escherichia coli. All analogues tested gave linear competitive inhibition kinetics with adenosylmethionine (AdoMet) as the variable substrate. Comparison of the Ki values obtained leads to the following conclusions concerning the specificity of the AdoMet-AdoHcy binding site on the enzyme: (i) the terminal amino group of the amino acid moiety is necessary for activity; (ii) both a chiral change of the asymmetric carbon atom of homocysteine and the presence of the terminal carboxyl group contribute little towards inhibitory activity; (iii) analogues in which the amino function of the adenyl moiety is modified or substituted are still potent inhibitors; (iv) inhibitor specificity is considerably reduced when adenine is replaced by a pyrimidine base.
腺苷高半胱氨酸(AdoHcy)的结构类似物已作为从大肠杆菌中获得的一种tRNA(尿嘧啶-5-)-甲基转移酶制剂的抑制剂进行了测试。所有测试的类似物均以腺苷甲硫氨酸(AdoMet)作为可变底物呈现线性竞争性抑制动力学。通过比较所获得的Ki值得出了关于该酶上AdoMet - AdoHcy结合位点特异性的以下结论:(i)氨基酸部分的末端氨基对于活性是必需的;(ii)高半胱氨酸不对称碳原子的手性变化以及末端羧基的存在对抑制活性贡献不大;(iii)腺苷部分的氨基功能被修饰或取代的类似物仍然是强效抑制剂;(iv)当腺嘌呤被嘧啶碱基取代时,抑制剂特异性会显著降低。